Correlation Between Ningbo MedicalSystem and Wuhan Hvsen

Can any of the company-specific risk be diversified away by investing in both Ningbo MedicalSystem and Wuhan Hvsen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ningbo MedicalSystem and Wuhan Hvsen into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Ningbo MedicalSystem Biotechnology and Wuhan Hvsen Biotechnology, you can compare the effects of market volatilities on Ningbo MedicalSystem and Wuhan Hvsen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ningbo MedicalSystem with a short position of Wuhan Hvsen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ningbo MedicalSystem and Wuhan Hvsen.

Diversification Opportunities for Ningbo MedicalSystem and Wuhan Hvsen

0.87

Correlation Coefficient

Ningbo MedicalSystem  Wuhan Hvsen

Very poor diversification

The 3 months correlation between Ningbo and Wuhan is 0.87. Overlapping area represents the amount of risk that can be diversified away by holding Ningbo MedicalSystem Biotechno and Wuhan Hvsen Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Wuhan Hvsen Biotechnology and Ningbo MedicalSystem is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ningbo MedicalSystem Biotechnology are associated (or correlated) with Wuhan Hvsen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Wuhan Hvsen Biotechnology has no effect on the direction of Ningbo MedicalSystem i.e., Ningbo MedicalSystem and Wuhan Hvsen go up and down completely randomly.

Pair Corralation between Ningbo MedicalSystem and Wuhan Hvsen

Assuming the 90 days trading horizon Ningbo MedicalSystem is expected to generate 7.81 times less return on investment than Wuhan Hvsen. But when comparing it to its historical volatility, Ningbo MedicalSystem Biotechnology is 1.47 times less risky than Wuhan Hvsen. It trades about 0.02 of its potential returns per unit of risk. Wuhan Hvsen Biotechnology is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest  1,074  in Wuhan Hvsen Biotechnology on December 24, 2024 and sell it today you would earn a total of  175.00  from holding Wuhan Hvsen Biotechnology or generate 16.29% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

Ningbo MedicalSystem Biotechno  vs.  Wuhan Hvsen Biotechnology

Ningbo MedicalSystem

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Ningbo MedicalSystem Biotechnology are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Ningbo MedicalSystem is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Wuhan Hvsen Biotechnology

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Wuhan Hvsen Biotechnology are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Wuhan Hvsen sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Ningbo MedicalSystem and Wuhan Hvsen

The main advantage of trading using opposite Ningbo MedicalSystem and Wuhan Hvsen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ningbo MedicalSystem position performs unexpectedly, Wuhan Hvsen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Wuhan Hvsen will offset losses from the drop in Wuhan Hvsen's long position.

The idea behind Ningbo MedicalSystem Biotechnology and Wuhan Hvsen Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.